Functional assessment of a skin care system in patients on chemotherapy

Skin Pharmacology and Physiology

Volumn 20, Issue 5, 2007, Pages 253-259

  Fluhr, J W ^a   Miteva, M ^a   Primavera, G ^b   Ziemer, M ^a   Elsner, P ^a   Berardesca, E ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Antidry emulsion; Antidry lotion; Cancer; Chemotherapy; Dry skin; Skin care system; Skin toxicity

Indexed keywords

EMOLLIENT AGENT;

ADULT; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY SKIN; FEMALE; FOREARM; FUNCTIONAL ASSESSMENT; HUMAN; HYDRATION; MALE; PRIORITY JOURNAL; SEBUM; SKIN CARE; SKIN SENSITIVITY; SKIN WATER LOSS; STRATUM CORNEUM; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ANTINEOPLASTIC AGENTS; EMOLLIENTS; EMULSIONS; EPIDERMIS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; NEOPLASMS; SKIN DISEASES; SKIN PHYSIOLOGY; WATER LOSS, INSENSIBLE;

EID: 34548166794     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104423     Document Type: Conference Paper

References (38)

1. Alley E, Green R, Schuchter L: Cutaneous toxicities of cancer therapy. Curr Opin Oncol 2002;14:212-216.
2. Branzan AL, Landthaler M, Szeimies R-M: Skin changes with chemotherapy. Hautarzt 2005;56:591-602.
3. Guillot B, Bessis D, Dreure O: Mucocutaneous side effects of antineoplastic chemotherapy. Expert Opin Drug Saf 2004;3:579-587.
4. Bronner AK, Hood AF: Cutaneous complications of chemotherapeutic agents. J Am Acad Dermatol 1983;9:645-663.
5. DeSpain JD: Dermatologic toxicities of chemotherapy. Semin Oncol 1992;19:501-507.
6. Koppel RA, Boh E: Cutaneous reactions to chemotherapeutic agents. J Am Med Sci 2001;321:327-335.
7. Young HS, Khan ASA, Kendra JR, Coulson IH: The cutaneous side-effects of hydroxyurea. Clin Lab Haematol 2000;22:229-232.
8. Vassallo C, Passamonti F, Merante S, Ardigo M, Nolli G, Mangiacavalli S, Borroni G: Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia. Clin Exp Dermatol 2001;26:141-148.
9. Burns DA, Sarkany I, Gaylarde P: Effects of hydroxyurea therapy on normal skin: a case report. Clin Exp Dermatol 1980;5:447-449.
10. Gauthier O, Gauthier JP, Bret-Dibat C: Atrophie cutaneéau cours de traitements prolongés par hydroxyurée. Ann Dermatol Venereol 1996;123:727-731.
11. Proksch E, Lachapelle JM: The management of dry skin with topical emollients - Recent perspectives. J Dtsch Dermatol Ges 2005;3:768-774.
12. Pinnagoda J, Tupker RA, Agner T, Serup J: Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990;22:164-178.
13. Berardesca E: EEMCO guidance for the assessment of stratum corneum hydration: electrical methods. Skin Res Technol 1997;3:126-132.
14. Rogiers V; EEMCO Group: EEMCO guidance for the assessment of transepidermal water loss in cosmetic sciences. Skin Pharmacol Appl Skin Physiol 2001;14:117-128.
15. Parra JL, Paye M; EEMCO Group: EEMCO guidance for the in vivo assessment of skin surface pH. Skin Pharmacol Appl Skin Physiol 2003;16:188-202.
16. Pierard GE, Pierard-Franchimont C, Marks R, Paye M, Rogiers V; EEMCO Group: EEMCO guidance for the in vivo assessment of skin greasiness. Skin Pharmacol Appl Skin Physiol 2000;13:372-389.
17. Loden M: Transepidermal water loss and dry skin;in Fluhr JW, Elsner P, Berardesca E, Maibach H (eds): Bioengineering of the Skin Water and the Stratum Corneum. Boca Raton, CRC Press LLC, 2005, pp 171-184.
18. Fischer TW, Wigger-Alberti W, Elsner P: Assessment of 'dry skin': current bioengineering methods and test designs. Skin Pharmacol Appl Skin Physiol 2001;14:183-195.
19. Wertz PW, Michniak BB: Hydration and lipids; in Fluhr JW, Elsner P, Berardesca E, Maibach H (eds): Bioengineering of the Skin Water and the Stratum Corneum. Boca Raton, CRC Press LLC, 2005, pp 359-367.
20. Loden M: Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003; 4:771-788.
21. Saint-Leger D, Francois AM, Leveque JL, Stoudemayer TJ, Kligman AM, Grove G: Stratum corneum lipids in skin xerosis. Dermatologica 1989;178:151-155.
22. Loden M, Lindberg M: Testing of moisturizers; in Fluhr JW, Elsner P, Berardesca E, Maibach H (eds): Bioengineering of the Skin Water and the Stratum Corneum. Boca Raton, CRC Press LLC, 2005, pp 387-405.
23. Rawlings AV, Matts PJ: Stratum corneum moisturization at the molecular level: an update in reaction to the dry skin cycle. J Invest Dermatol 2005;124:1099-1110.
24. Rawlings AV, Harding CR: Moisturization and skin barrier function. Dermatol Ther 2004;17:43-48.
25. Subramanyan K: Role of mild cleansing in the management of patient skin. Dermatol Ther 2004;17:26-34.
26. Fluhr JW, Ennen J: Standardized washing models: facts and requirements. Skin Res Technol 2004;10:141-143.
27. Fluhr JW, Gloor M, Gehring W: Physiology of skin cleaning and functional mechanism of bath oils;in Berardesca E, Picardo M, Pigatto P (eds): Irritant Contact Dermatitis Proceedings of the 3rd International Symposium (ISICD). Milan, Medical Publishing & New Media, 2000, pp 291-307.
28. Grunewald AM, Gloor M, Gehring W, Kleesz P: Damage to the skin by repetitive washing. Contact Dermatitis 1995;32:225-232.
29. Bornkessel A, Flach M, Arens-Corell M, Elsner P, Fluhr JW: Functional assessment of a washing emulsion for sensitive skin: mild impairment of stratum corneum hydration, pH, barrier function, lipid content, integrity and cohesion in a controlled washing test. Skin Res Technol 2005;11:53-60.
30. Seidenari S, Francomano M, Mantovani L: Baseline biophysical parameters in subjects with sensitive skin. Contact Dermatitis 1998; 38:311-315.
31. Muizzuddin N, Marenus KD, Maes DH: Factors defining sensitive skin and its treatment. Am J Contact Dermat 1998;9:170-175.
32. Loden M, Buraczewska I, Edlund F: Irritation potential of bath and shower oils before and after use: a double-blind randomized study. Br J Dermatol 2004;150:1142-1147.
33. Fluhr JW, Elias PM: Stratum corneum pH: formation and function of the 'acid mantle'. Exog Dermatol 2002;1:163-175.
34. Holleran WM, Takagi M, Menoon GK, Legler G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993;91:1656-1664.
35. Hachem JP, Crumrine D, Fluhr J, Brown B, Feingold KR, Elias PM: pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003;121:345-353.
36. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM: Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001;117:44-51.
37. Gfatter R, Hackl P, Braun F: Effects of soaps and detergents on skin surface pH, stratum corneum hydration and fat content in infants. Dermatology 1997;195:258-262.
38. Korting HC, Kober M, Mueller M, Braun-Falco O: Difference in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0: results of a cross-over trial in healthy volunteers. Acta Dermatol Venereol 1990;70:429-431.